ライフサイエンスコーパス: behavior therapy

1 ) consisting of diet, physical activity, and behavior therapy.

2 h poor response to medications and cognitive behavior therapy.

3 that included multiple elements of cognitive behavior therapy.

4 guided self-help, an adaptation of cognitive behavior therapy.

5 strongly to the ideal prototype of cognitive behavior therapy.

6 sions and hallucinations following cognitive behavior therapy.

7 treatment of bulimia nervosa with cognitive behavior therapy.

8 atment outcomes for imipramine and cognitive behavior therapy.

9 were relatively less responsive to cognitive behavior therapy.

10 3 weeks with intensive individual cognitive behavior therapy.

11 tation of the skills emphasized in cognitive behavior therapy.

12 escitalopram and poor response to cognitive behavior therapy.

13 with combination escitalopram and cognitive behavior therapy.

14 /d) or 16 sessions of manual-based cognitive behavior therapy.

15 tch to a different medication plus cognitive behavior therapy.

16 RI or venlafaxine, with or without cognitive behavior therapy.

17 lorie diet, increased physical activity, and behavior therapy.

18 nal and social rhythm therapy, and cognitive behavior therapy.

19 requires effective treatment options beyond behavior therapy.

20 primary analysis: 12 remitters to cognitive behavior therapy, 11 remitters to escitalopram, 9 nonres

21 ivational enhancement therapy plus cognitive behavior therapy (12 sessions over 6 months), or usual c

22 for a second testing session after cognitive behavior therapy; 13 comparison children participated a

23 Before and after 7-week group behavior therapy, 17 patients with DSM-III-R OCD were as

24 bined) was significantly lower for cognitive behavior therapy (22%) than for nutritional counseling (

25 ropout rate was similar to regular cognitive behavior therapy (30%) and unrelated to treatment arm.

26 tly more of the patients receiving cognitive behavior therapy (44%) than nutritional counseling (7%).

27 gher rate than the group receiving cognitive behavior therapy (53% versus 22%).

28 gher proportion of patients in the cognitive behavior therapy (71%) and supportive stress-management

29 hose who completed self-management cognitive behavior therapy achieved high-end state functioning at

30 ls and other human disorders suggesting that behavior therapy acts by way of long-term potentiation o

31 The effects of dialectical behavior therapy adapted for the treatment of binge/purg

32 The use of dialectical behavior therapy adapted for treatment of bulimia nervos

33 A course of cognitive behavior therapy, added to the antipsychotic regimen, is

34 s are treated with similar symptom-relieving behavior therapies and medications.

35 tation strategy for exposure-based cognitive behavior therapy and (2) conducted in humans diagnosed a

36 n the follow-up study: 25 received cognitive behavior therapy and 28 received relaxation therapy.

37 f 68% of the patients who received cognitive behavior therapy and 36% who received relaxation therapy

38 therapy, and treatments combining cognitive behavior therapy and contingency management.

39 Cognitive behavior therapy and graded exercise can be effective in

40 The relation between response to cognitive behavior therapy and HPA activity was not explained by c

41 Dialectical behavior therapy and interpersonal psychotherapy may als

42 promising, as is a combination of cognitive-behavior therapy and morning bright light.

43 CALM (cognitive behavior therapy and pharmacotherapy medication recommen

44 Overall, behavior therapy and pharmacotherapy produce similar sho

45 CALM (cognitive behavior therapy and pharmacotherapy recommendations) an

46 ) was associated with remission to cognitive behavior therapy and poor response to escitalopram, whil

47 Psychotherapies, most notably dialectical behavior therapy and psychodynamic approaches, are effec

48 Both cognitive behavior therapy and supportive stress management are ef

49 e constructs across six domains; dialectical behavior therapy and supportive treatment were associate

50 luding habit reversal or acceptance-enhanced behavior therapy) and medication (serotonin reuptake inh

51 o escitalopram, 9 nonresponders to cognitive behavior therapy, and 6 nonresponders to escitalopram.

52 ed with motivational interviewing, cognitive behavior therapy, and family intervention over routine p

53 ed with motivational interviewing, cognitive behavior therapy, and family or caregiver intervention.

54 ivational enhancement therapy (MET)/CBT, MET behavior therapy, and pharmacological treatment.

55 ement, relapse prevention, general cognitive behavior therapy, and treatments combining cognitive beh

56 Dialectical behavior therapy appears to be uniquely effective in red

57 a psychological treatment based on cognitive behavior therapy, appears ineffective, but treatment wit

58 utamatergic pathways and that the effects of behavior therapy are potentiated by an NMDA agonist.

59 for panic disorder, exposure-based cognitive behavior therapy, are reviewed, and their application to

60 the first empirical evaluation of cognitive behavior therapy as a posthospitalization treatment for

61 aimed to evaluate whether blended cognitive behavior therapy (bCBT) can reduce the severity of FCR i

62 tion; n = 32 with complete data) or Internet behavior therapy (behavior therapy; n = 33 with complete

63 d with obese adolescents in combination with behavior therapy (BT).

64 comprehensive program of diet, exercise, and behavior therapy but are typically prescribed with minim

65 cognitive behavior therapy favored cognitive behavior therapy, but tests comparing the two modalities

66 nin reuptake inhibitors (SRIs) and cognitive behavior therapy by exposure and ritual prevention are b

67 Cognitive behavior therapy (CBT) among youth with obsessive-compul

68 mized controlled trial comparing a cognitive behavior therapy (CBT) and pharmacotherapy intervention

69 Cognitive behavior therapy (CBT) can be effective for late-life ge

70 l effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered by oncolo

71 ffectiveness of family therapy and cognitive behavior therapy (CBT) guided self-care in adolescents w

72 Cognitive behavior therapy (CBT) has been established as efficacio

73 Cognitive behavior therapy (CBT) has been identified as the treatm

74 Grief-focused cognitive behavior therapy (CBT) has been shown to be effective in

75 ation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional benefit.

76 fluoxetine hydrochloride therapy, cognitive behavior therapy (CBT), and their combination in adolesc

77 wn for family therapy, followed by cognitive behavior therapy (CBT), motivational enhancement therapy

78 ake inhibitor (SSRI) sertraline or cognitive behavior therapy (CBT), participants completed an emotio

79 d depressed individuals respond to cognitive behavior therapy (CBT).

80 ersonal and social rhythm therapy, cognitive behavior therapy [CBT], or family-focused therapy), and

81 BWL) and guided self-help based on cognitive behavior therapy (CBTgsh) have both resulted in short-te

82 ses in binge/purge behavior with dialectical behavior therapy compared to the waiting-list condition.

83 Cognitive behavior therapy compared with EUC significantly improve

84 of treatment, participants in both cognitive behavior therapy conditions had significant reductions i

85 the antidepressant medication and cognitive behavior therapy conditions of the Treatment of Depressi

86 Dialectical behavior therapy (DBT) is a treatment for suicidal behav

87 Dialectical behavior therapy (DBT) is an empirically supported treat

88 Extinction, the laboratory analog of behavior therapy, does not erase conditioned fear memori

89 forms of psychotherapy other than cognitive behavior therapy, even though there is little informatio

90 durable, with 87% of available responders to behavior therapy exhibiting continued benefit 6 months f

91 aring antidepressant medication to cognitive behavior therapy favored cognitive behavior therapy, but

92 The manual-based dialectical behavior therapy focused on training in emotion regulati

93 to either escitalopram oxalate or cognitive behavior therapy for 12 weeks.

94 ents the effects of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and

95 acebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compulsive, and

96 s who will and will not respond to cognitive behavior therapy for bulimia nervosa, potentially allowi

97 Cognitive behavior therapy for chronic fatigue syndrome can produc

98 Although cognitive behavior therapy for insomnia (CBT-I) has been establish

99 reports on an open-label trial of cognitive behavior therapy for insomnia and disturbing dreams in c

100 Components of cognitive behavior therapy for insomnia, especially stimulus contr

101 amatergic receptor, enhances the efficacy of behavior therapy for obsessive-compulsive disorder (OCD)

102 of changes in caudate nucleus function with behavior therapy for obsessive-compulsive disorder.

103 e use of D-cycloserine as an augmentation of behavior therapy for OCD and extend findings in animals

104 Five aspects of cognitive behavior therapy for schizophrenia are addressed: 1) evi

105 road perspective on the subject of cognitive behavior therapy for schizophrenia for the American read

106 trength of the evidence supporting cognitive behavior therapy for schizophrenia suggests that this te

107 ice and data supporting the use of cognitive behavior therapy for schizophrenia.

108 irical evidence, to be superior to cognitive behavior therapy for the acute treatment of severely dep

109 support the efficacy of pharmacotherapy and behavior therapy for the treatment of insomnia, no meta-

110 dy of evidence supports the use of cognitive behavior therapy for the treatment of schizophrenia.

111 combination of diet, physical activity, and behavior therapy (frequently referred to as lifestyle mo

112 Dialectical behavior therapy (g = 0.34; 95% CI, 0.15-0.53) and psych

113 ivational enhancement therapy plus cognitive behavior therapy group and -0.19% (CI, -0.53% to 0.16%)

114 The behavior therapy group lost a mean (SD) of 4.0 (2.8) kg

115 Repeated-measures analyses showed that the behavior therapy group lost more weight than the educati

116 Participants in the behavior therapy group received additional behavioral pr

117 waist circumference were also greater in the behavior therapy group than in the education group at bo

118 were employed, but patients in the cognitive behavior therapy group worked significantly more mean ho

119 Cognitive behavior therapy had greater and more durable effects th

120 Cognitive behavior therapy has fared as well as antidepressant med

121 often labeled as the generic term cognitive behavior therapy, has been shown to be effective in redu

122 tary therapy, physical activity, and ongoing behavior therapy have been endorsed by the National Inst

123 rents' views of the credibility of cognitive behavior therapy improved compared with parents' views o

124 d with 18 sessions of manual-based cognitive behavior therapy in a three-site study.

125 efficacy of any psychotherapy, and cognitive behavior therapy in particular, in posthospitalization c

126 6Met genotype predicts response to cognitive behavior therapy in PTSD and is in accord with evidence

127 otherapy, we examined responses to cognitive behavior therapy in relation to electroencephalographic

128 therefore investigated response to cognitive behavior therapy in relation to pretreatment measures of

129 s of antidepressant medication and cognitive behavior therapy in the severely depressed outpatient su

130 nificantly more patients receiving cognitive behavior therapy, in relation to those in relaxation the

131 Guided self-help based on cognitive behavior therapy is a first-line treatment option for mo

132 Comprehensive behavior therapy is a safe and effective intervention fo

133 tivational enhancement therapy and cognitive behavior therapy is feasible for adults with poorly cont

134 Cognitive behavior therapy is more efficacious than SBFT or NST fo

135 rapy (often labeled generically as cognitive behavior therapy) is efficacious either alone or as an a

136 e completer group, self-management cognitive behavior therapy led to greater reductions in PTSD, depr

137 nt-to-treat group, self-management cognitive behavior therapy led to sharper declines in daily log-on

138 Self-management cognitive behavior therapy may be a way of delivering effective tr

139 Cognitive behavior therapy may benefit the large number of patient

140 Behavior therapy may offer an alternative but has not be

141 Hamilton scores were lower in the cognitive behavior therapy (mean [standard error], 5.5 [1.0]) and

142 mized, controlled trials comparing cognitive behavior therapy, medication, and their combination to p

143 ly assigned to 8 sessions during 10 weeks of behavior therapy (n = 61) or a control treatment consist

144 Cognitive behavior therapy (n = 70) conducted in the primary care

145 ndomly assigned to self-management cognitive behavior therapy (N=24) or supportive counseling (N=21).

146 mmended standard treatment (either cognitive behavior therapy [N=36] or imipramine [N=22]).

147 rvention (8 weeks of manual-guided cognitive behavior therapy) (n = 90), or referral to community men

148 complete data) or Internet behavior therapy (behavior therapy; n = 33 with complete data).

149 g and the acknowledged preclinical model for behavior therapy of human anxiety.

150 randomly assigned to 20 weeks of dialectical behavior therapy or 20 weeks of a waiting-list compariso

151 cted to receive 1 year of either dialectical behavior therapy or general psychiatric management for b

152 One year of either dialectical behavior therapy or general psychiatric management was a

153 isorder than treatment with either cognitive behavior therapy or imipramine; results obtained with em

154 e treated for 16 weeks with either cognitive behavior therapy or interpersonal psychotherapy alone (p

155 ad relapsed following, a course of cognitive behavior therapy or interpersonal psychotherapy were ran

156 y assigned to 1 year of outpatient cognitive behavior therapy or nutritional counseling.

157 signed to receive the two kinds of cognitive behavior therapy or received standard community treatmen

158 Twelve weeks of cognitive behavior therapy or supportive stress management.

159 nsference-focused psychotherapy, dialectical behavior therapy, or supportive treatment and received m

160 rbid posttraumatic stress disorder (PTSD) on behavior therapy outcome for obsessive-compulsive disord

161 Interventions: Site-specific behavior therapy plus 10 mg of sibutramine or placebo.

162 tinction of the additive effect of cognitive behavior therapy plus motivational enhancement therapy f

163 bined psychotherapy (8 sessions of cognitive behavior therapy) plus pharmacotherapy (citalopram).

164 underwent an 8-week exposure-based cognitive behavior therapy program and provided mouth swabs or sal

165 Sibutramine added to a behavior therapy program reduced BMI and body weight mor

166 In addition, adherence to the cognitive behavior therapy prototype yielded more positive correla

167 Behavior therapy remains the recommended first-line trea

168 ograms were complying with the new cognitive behavior therapy requirement.

169 Behavior therapy responders had significant (P < .05) bi

170 tion between sleep abnormality and cognitive behavior therapy response was not significant in the com

171 Behavior therapy resulted in a greater reduction in slee

172 Cognitive behavior therapy resulted in more rapid relief in interv

173 he interpersonal psychotherapy and cognitive behavior therapy sessions adhered most strongly to the i

174 of interpersonal psychotherapy and cognitive behavior therapy sessions conducted as part of the NIMH

175 One hour before each of the behavior therapy sessions, the participants received eit

176 Then they received 10 behavior therapy sessions.

177 Cognitive behavior therapy showed a lower rate of MDD at the end o

178 Both groups receiving cognitive behavior therapy sustained greater improvement in substa

179 d to 1 of 3 treatments: individual cognitive behavior therapy, systemic behavior family therapy (SBFT

180 Use of a specialist behavior therapy team in addition to standard treatment

181 ts associated with treatment by a specialist behavior therapy team.

182 Community-based specialist behavior therapy teams may be helpful in managing challe

183 More participants in the behavior therapy than education group achieved the 5% we

184 can lead to the development of drugs and/or behavior therapies that reduce the impact that these cue

185 mpare the efficacy of a manualized cognitive behavior therapy that addresses both posttraumatic stres

186 (seeking safety) with a manualized cognitive behavior therapy that addresses only substance abuse (re

187 After behavior therapy the patients evidenced significant decr

188 d after 16 weeks of treatment with cognitive behavior therapy to determine the stability or reversibi

189 d treatment is for the addition of cognitive behavior therapy to pharmacotherapy for patients with ag

190 borderline personality disorder: dialectical behavior therapy, transference-focused psychotherapy, an

191 tients with BED, with IPT (or full cognitive behavior therapy) used for patients with low self-esteem

192 ef interpersonal psychotherapy and cognitive behavior therapy using the Psychotherapy Process Q-Set,

193 d, Internet-based, self-management cognitive behavior therapy versus Internet-based supportive counse

194 n a randomized controlled trial of cognitive behavior therapy versus relaxation therapy for chronic f

195 evaluated the long-term outcome of cognitive behavior therapy versus relaxation therapy for patients

196 Behavior therapy was associated with a significantly gre

197 Dialectical behavior therapy was associated with better outcomes in

198 D-cycloserine versus placebo augmentation of behavior therapy was conducted in 23 OCD patients.

199 Cognitive behavior therapy was initiated at a median of 17 days af

200 Response to inpatient cognitive behavior therapy was inversely associated with pretreatm

201 Cognitive behavior therapy was markedly underused.

202 Cognitive behavior therapy was positively evaluated and was still

203 Cognitive behavior therapy was significantly more effective than n

204 Cognitive behavior therapy was superior to usual care at most poin

205 s of antidepressant medication and cognitive behavior therapy were compared within each of the four s

206 erence-focused psychotherapy and dialectical behavior therapy were significantly associated with impr

207 Patients receiving behavior therapy who were available for assessment at 6

208 ariance treatment (escitalopram or cognitive behavior therapy) x outcome (remission or nonresponse) i